Coronavirus patients with high-risk comorbidities are being given a newly approved antibody drug, which limits the virus’s ability to replicate in the body
- Follow our Covid live blog for the latest updates
- Restrictions: NSW; Vic; Qld; borders
- Vaccine rollout tracker; get our free news app; get our morning email briefing
Australia’s treatment of Covid-19 patients has improved with doctors claiming new drug options and increased experience with the virus may help ease the burden on hospitals.
In August, Australia’s drug regulator, the Therapeutic Goods Administration, approved a novel antibody treatment called sotrovimab. The drug will prevent those most at risk from developing severe disease.
Read the original article at The Guardian